XOMA Royalty (XOMA) Restructuring Costs (2012 - 2026)
XOMA Royalty (XOMA) reported Restructuring Costs of $11.0 million for Q1 2026, up 55.7% on a YoY basis from $7.1 million in Q1 2025, and up 0.65% sequentially from $11.0 million in Q4 2025.
XOMA Royalty (XOMA) Restructuring Costs (2012 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 11 years of Restructuring Costs data on file, last reported at $11.0 million in Q1 2026.
- For the quarter ending Q1 2026, Restructuring Costs rose 55.7% year-over-year to $11.0 million; the trailing twelve-month figure through Mar 2026 stood at $35.1 million (up 13.86% YoY), and the FY2025 full-year result was $29.4 million, down 6.57% from the prior year.
- Restructuring Costs improved to $11.0 million in Q1 2026, from $11.0 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $18.1 million in Q4 2023 to a low of $4.1 million in Q1 2023.
- A 4-year average of $8.8 million and a median of $7.1 million in 2024 frame the typical range for Restructuring Costs.
- Peak annual rise in Restructuring Costs reached 69.82% in 2024, while the deepest fall reached 64.24% in 2024.
- Tracing XOMA's Restructuring Costs over 4 years: stood at $18.1 million in 2023, then slumped by 64.24% to $6.5 million in 2024, then soared by 69.58% to $11.0 million in 2025, then increased by 0.65% to $11.0 million in 2026.
- Business Quant data shows XOMA's Restructuring Costs at $11.0 million in Q1 2026, $11.0 million in Q4 2025, and $6.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.04 Mn |
| Dec 31, 2025 | 10.97 Mn |
| Jun 30, 2025 | 5.98 Mn |
| Mar 31, 2025 | 7.09 Mn |
| Dec 31, 2024 | 6.47 Mn |
| Sep 30, 2024 | 6.99 Mn |
| Jun 30, 2024 | 10.26 Mn |
| Mar 31, 2024 | 7.02 Mn |
| Dec 31, 2023 | 18.08 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2018 | 543,000.00 |
| Sep 30, 2018 | 909,000.00 |
| Jun 30, 2018 | 459,000.00 |
| Jun 30, 2017 | 1.46 Mn |
| Mar 31, 2017 | 2.02 Mn |
| Dec 31, 2016 | 4.55 Mn |
| Jun 30, 2016 | -21,000.00 |
| Mar 31, 2016 | 36,000.00 |
| Dec 31, 2015 | 1.14 Mn |
| Sep 30, 2015 | 2.56 Mn |